PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -65.00 | -0.93% | 6,945.00 | 6,899.00 | 6,902.00 | 7,172.00 | 6,895.00 | 7,001.00 | 3,939,124 | 16:35:17 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 19,468.2 | 2,864.2 | 178.5 | 39.6 | 91,112 |
AstraZeneca's Initial Vaccine Volumes in Europe to Be Lower Than Expected
22/01/2021 7:09pm
Dow Jones News
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Dec 2020 to Feb 2021
By Adriano Marchese
AstraZeneca PLC said Friday that initial Covid-19 vaccine volumes in Europe will be lower than anticipated in January.
"While there is no scheduled delay to the start of shipments of our vaccine should we receive approval in Europe, initial volumes will be lower than originally anticipated," a spokesperson for the pharmaceutical company said.
AstraZeneca blamed the lower volumes on reduced yields at a manufacturing site within its European supply chain.
"We will be supplying tens of millions of doses in February and March to the European Union, as we continue to ramp up production volumes," the spokesperson added.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 22, 2021 13:54 ET (18:54 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
